Registry of Lobbyists
Version 1 of 8 (1996-03-26 to 1996-10-21) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.
| Organization: |
CANADIAN SOCIETY OF HOSPITAL PHARMACISTS (CSHP)
350 - 1145 HUNT CLUB ROAD OTTAWA, ON K1V 0Y3 Canada |
| Telephone number: | 613-736-9733 |
| Fax number: | 613-736-5660 |
| Responsible officer name and position during the period of this registration: | WILLIAM J LESLIE, EXECUTIVE DIRECTOR |
| Description of the organization's activities: | THE CANADIAN SOCIETY OF HOSPITAL PHARMACISTS (CSHP) IS THE NATIONAL VOLUNTARY ORGANIZATION OF PHARMACISTS WHO SHARE AN INTEREST IN PHARMACY PRACTICE IN HOSPITALS AND RELATED HEALTH CARE SETTINGS.CSHP'S VISION '97 IS: COMMITTED CAREGIVERS.... CHALLENGING EACH OTHER THROUGH SHARING & EDUCATION , LEADING PHARMACY THROUGH STANDARDS & INNOVATION. THE RELATED VISION OBJECTIVES ARE: 1-ENCOURAGE MEMBERS TO DEVELOP & SHARE INNOVATIVE DIRECT PATIENT CARE PRACTIVE MODELS & EXPERIENCE 2-PROMOTE THE DIRECT PATIENT CARE ROLE OF THE PHARMACIST TO: MEMBERS, PATIENTS, EDUCATORS, STUDENTS, GOV'T, HEALTH CARE PROVIDERS & ORGANIZATIONS 3-PROVIDE ACCESSIBLE EDUCATION TO ASSIST MEMBERS IN ACHIEVING A DIRECT PATIENT CARE ROLE |
| Organization's membership or classes of membership: | 1-ACTIVE MEMBERS ARE PHARMACISTS LICENSED OR REGISTERED WITH A PHARMACY REGULATORY BODY IN CANADA OR PERSONS WITH A PROFESSIONAL DEGREE IN PHARMACY2-HONORARY MEMBERS - ELECTED BY A 2/3 VOTE OF THE COUNCIL OF THE SOCIETY3-STUDENT MEMBERS ARE PERSONS ENROLLED IN A BACCALAUREATE DEGREE PROGRAM IN PHARMACY4-SUPPORTING MEMBERS ARE PERSONS NOT ELIGIBLE FOR OTHER MEMBERSHIP CATEGORIES5-CORPORATE MEMBERS ARE CORPORATIONS WHO SUPPORT THE OBJECTIVES OF AND PAY FEES TO THE SOCIETY |
| Was the organization funded in whole or in part by any domestic or foreign government institution in the last completed financial year? | No |
| Name: | WILLIAM LESLIE |
| Position title: | EXECUTIVE DIRECTOR |
| Public offices held: | N/A. Disclosure of this information was not a requirement prior to June 20, 2005. |
| Federal departments or organizations which have been or will be communicated with during the course of the undertaking: | DRUGS DIRECTORATE, HEALTH PROTECTION BRANCH, Health Canada (HC), Patented Medicine Prices Review Board (PMPRB) |
|
Communication techniques that have been used or are expected to be used in the course of the undertaking:
|
Informal communications, Meetings, Telephone calls, Written communications, whether in hard copy or electronic format |
| Subject Matter: Areas of Concern: | Health |
| Subject Matter: Retrospective: | RESPONSES TO REQUESTS FOR INPUT: DRUGS DIRECTORATE SPECIAL ACCESS PROGRAM; DRUGS DIRECTORATE DRUG IDENTIFICATION NUMBER WORKING PROGRAM; DRUGS DIRECTORATE CLINICAL TRIAL REVIEW POLICY; DRUGS DIRECTORATE GOOD MANUFACTURING PRACTICES REVISION; LETTER TO DRUGS DIRECTORATE SUPPORTING PROPOSAL FOR LABEL DISCLOSURE OF NON-MEDICAL INGREDIENTS; CAN. GAZETTE PART I RE DEREGULATORY INITIATIVE FOR FAMOTIDINE; DRUGS DIRECTORATE DRUG LICENSING FRAMEWORK; DRUGS DIRECTORATE DIRECT TO CONSUMER ADVERTISING POLICY; DRUGS DIRECTORATE DEREGULATORY INITIATIVE FOR SODIUM CROMOGLYCATE; DRUGS DIRECTORATE POLICY ON HOMEOPATHIC PRODUCTS. |
| Subject Matter: Prospective: | RESPOND TO RELEVANT HEALTH RELATED ITEMS PUBLISHED IN CANADA GAZETTE; ALSO TO ADVANCE NOTICE REGULATORY LETTERS FROM DRUGS DIRECTORATE.RESPOND TO REQUESTS FOR COMMENT FROM PMPRB.PLANNING TO MEET WITH DRUGS DIRECTORATE REGARDING APPLICATION OF GMP TO HOSPITAL PHARMACY.PLANNING TO MEET WITH DRUGS DIRECTORATE PHARMACEUTICAL POLICY DIVISION TO DISCUSSS COMING INITITATIVES; FACT FINDING.CONTINUED INPUT ON DIRECT TO CONSUMER ADVERTISING. |